Factors influencing antimicrobial utilization at a university hospital during a period of 11 years

International Journal of Clinical Pharmacology and Therapeutics

Volumn 41, Issue 7, 2003, Pages 287-293

  Vlahovic Palcevski, V ^a   Palcevski, G ^a   Mavric, Z ^a   Francetic, I ^b  

^a KBC RIJEKA   (Croatia)

^b KBC Zagreb   (Croatia)

Author keywords

Antibiotics; Antimicrobial utilization; Defined daily dose; Hospital

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; BENZATHINE PENICILLIN; CEFADROXIL; CEFALEXIN; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CHLORAMPHENICOL; CLOXACILLIN; DOXYCYCLINE; ENZYME INHIBITOR; MACROLIDE; METACYCLINE; OXYTETRACYCLINE; PENICILLIN DERIVATIVE; PENICILLIN G; PENICILLIN V; PIPERACILLIN; PROCAINE PENICILLIN; SULTAMICILLIN; TETRACYCLINE; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG;

ANTIMICROBIAL THERAPY; ARTICLE; CONTROLLED STUDY; CROATIA; DOSE RESPONSE; DRUG COST; DRUG FORMULARY; DRUG UTILIZATION; HEALTH CARE AVAILABILITY; HEALTH CARE POLICY; HUMAN; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; PROSPECTIVE PRICING; PURCHASING; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL;

EID: 0037592391     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP41287     Document Type: Article

References (22)

1. Burke JP, Pestotnik SL 1997 The quality of antibiotic use and the quality of measuring it (Editorial). Curr Opin Infect Dis 10: 289-291
2. Col NF, O'Conor RW 1987 Estimating worldwide current antibiotic usage: report of Task Force 1. Rev Infect Dis Suppl 3: S232-243
3. Echols RM, Kowalsky SF 1984 The use of antibiotic order form for antibiotic utilization review: influence on physicians' prescribing patterns. J Infect Dis 150: 803-807
4. Gould IM, Jappy B 2000 Trends in hospital antimicrobial prescribing after 9 years of stewardship. J Antimicrob Chemother 45: 913-917
5. Jarvis WR 1996 Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls: the complexity of the problem. Infect Control Hosp Epidemiol 17: 490-495
6. John JF, Fishman NO 1997 Programmatic role of the infectious disease physician in controlling antimicrobial costs in hospitals. Clin Infect Dis 24: 471-485
7. Kunin CM, Johansen KS, Worning AM, Daschner FD 1990 Report of a symposium on use and abuse of antibiotics worldwide. Rev Infect Dis 12: 12-19
8. Marr JJ, Moffet HL, Kunin CM 1988 Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis 157: 869-876
9. Masterson RG 1999 Antibiotic policies and the role of strategic hospital leadership. J Hosp Infect Suppl 43: S261-S264
10. Molstad S, Cars O 1999 Major change in use of antibiotics following a national programme: Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA). Scand J Infect Dis 31: 191-195
11. Nathwani D 1999 How do you measure the impact of an antibiotic policy? J Hosp Infect (Suppl 43): S265-S268
12. Natsch S, Hekster YA, de Jong R et al 1998 Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis 17: 20-24
13. Pestotnik SL. Classen DC, Evans RS, Burke JP 1996 Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 124: 884-890
14. Simmons HE, Stolley PD 1974 This is medical progress? Trends and consequences of antibiotic use in the United States (commentary). JAMA 227: 1023-1028
15. Stobberingh E, Janknegt R, Wijnands G 1993 Antibiotic guidelines and antibiotic utilization in Dutch hospitals. J Antimicrob Chemother 32: 153-161
16. Vlahovic-Palcevski V, Vitezic D, Palcevski G 1997 Antibiotics utilization during the war period: influence of drug donations. Eur J Epidemiol 13: 859-862
17. Vlahovic-Palcevski V, Morovic M, Palcevski G 2000 Antibiotic utilization at the university hospital after introducing an antibiotic policy. Eur J Clin Pharmacol 56: 97-101
18. von Ferber L 2001 Type, scope and quality of drug utilization. Int J Clin Pharmacol Ther 39: 471-476
19. WHO Expert Committee on the Use of Essential Drugs 1998 WHO Model List. WHO Drug Information 12: 22-35
20. WHO 1999 Guidelines for Drug Donations (2nd ed). WHO, Geneva
21. WHO Collaborating Centre for Drug Statistics Methodology 2000 ATC Index with DDDs. WHO, Oslo
22. Woodvard RS, Medoff G, Smith MD, Gray JL III 1987 Antibiotic cost savings from formulary restrictions and physician monitoring in a medical school-affiliated hospital. Am J Med 83: 817-823